CN3727716
Expired
Supply of Hemlibra
The National Blood Authority engaged Roche Products Pty Ltd, an Australian private company based in Sydney, NSW, to supply Hemlibra under a limited-tender contract valued at AU$353,210,000 from October 2020 to June 2025. The procurement method was limited tender under exemption TR — 10.3.d.iii due to an absence of competition for technical reasons.
$353.2M
Contract Value
Contract Details
- Contract ID
- CN3727716
- Status
- active
- Financial Year
- FY21
- Category
- Drugs and Pharmaceutical(UNSPSC: 51000000)
Key Dates
- Publish Date
- 4 Nov 2020
- Signed Date
- 4 Nov 2020
- Start Date
- 31 Oct 2020
- End Date
- 29 June 2025
- Duration
- 4 years, 9 months
Procurement Information
- Procurement Method
- Limited tender
- Exemption Code
- TR
- Exemption Reason
- 10.3.d.iii. Supply by particular business: due to an absence of competition for technical reasons.
Supplier
ROCHE PRODUCTS PTY LTD
- ABN
- 70 000 132 865
- Entity Type
- Australian Private Company
- Location
- NSW